Serum Tumor Markers in Pancreatic Cancer—Recent Discoveries

By Rückert Felix   Pilarsky Christian   Grützmann Robert  

Cancers, Vol. 2, Iss. 2, 2010-06 ,pp. : 1107-1124

MDPI

Access to resources Recommend Favorite

Hypoxia Induced Tumor Metabolic Switch Contributes to Pancreatic Cancer Aggressiveness

By Vasseur Sophie   Tomasini Richard   Tournaire Roselyne   Iovanna Juan L.  

Cancers, Vol. 2, Iss. 4, 2010-12 ,pp. : 2138-2152

MDPI

Access to resources Recommend Favorite

Survival Analysis in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Chemoradiotherapy Followed by Surgery According to the International Consensus on the 2017 Definition of Borderline Resectable Cancer

By Hayasaki Aoi   Isaji Shuji   Kishiwada Masashi   Fujii Takehiro   Iizawa Yusuke   Kato Hiroyuki   Tanemura Akihiro   Murata Yasuhiro   Azumi Yoshinori   Kuriyama Naohisa   Mizuno Shugo   Usui Masanobu   Sakurai Hiroyuki  

Cancers, Vol. 10, Iss. 3, 2018-03 ,pp. : 65-65

MDPI

Access to resources Recommend Favorite

Distribution and Clinical Significance of Th17 Cells in the Tumor Microenvironment and Peripheral Blood of Pancreatic Cancer Patients

By He Songbing   Fei Min   Wu Yugang   Zheng Dingcheng   Wan Daiwei   Wang Liang   Li Dechun  

International Journal of Molecular Sciences, Vol. 12, Iss. 11, 2011-10 ,pp. : 7424-7437

MDPI

Access to resources Recommend Favorite

Aberrantly Over-Expressed TRPM8 Channels in Pancreatic Adenocarcinoma: Correlation with Tumor Size/Stage and Requirement for Cancer Cells Invasion

By Yee Nelson S.   Li Qin   Kazi Abid A.   Yang Zhaohai   Berg Arthur   Yee Rosemary K.  

Cells, Vol. 3, Iss. 2, 2014-05 ,pp. : 500-516

MDPI

Access to resources Recommend Favorite